Best AI clinical decision support tools 2026: UpToDate AI vs DynaMed vs iatroX

Key takeaways

Every major clinical reference platform now has a generative AI assistant: UpToDate Expert AI (Wolters Kluwer), Dyna AI (EBSCO), ClinicalKey AI (Elsevier), and newer entrants like OpenEvidence and Heidi Evidence. The era of keyword search in clinical reference is over.
The underlying technology is broadly similar — Retrieval-Augmented Generation (RAG) — but the quality of the retrieval corpus is what differentiates them. Tools grounded in curated, expert-reviewed content (UpToDate, DynaMed) produce more reliable outputs than those drawing from the open web.
UpToDate Expert AI is the market leader by brand trust and content depth, but it is expensive (~$530/year individual US; institutional pricing in the UK). Dyna AI is the first-mover in commercial AI deployment and offers strong evidence grading. ClinicalKey AI has the deepest textbook and journal library. OpenEvidence is free for verified US HCPs but US-centric.
iatroX occupies a unique position: free, MHRA-registered, UK-guideline-grounded, and purpose-built for NHS workflows and exam preparation. It is the only tool in this comparison that is genuinely free for all clinicians and students without professional verification or institutional subscription.
For UK clinicians, the decision is not "which single tool should I use?" but "which combination gives me the best coverage?" We recommend a tiered approach: iatroX for daily UK-guideline queries, a major paid platform (UpToDate or DynaMed) for deep reference when available, and awareness of the newer AI entrants.

The 2026 landscape: what has changed

The clinical decision support market in early 2026 looks fundamentally different from even 12 months ago:

UpToDate launched Expert AI in late 2025 — a conversational AI assistant grounded in the UpToDate editorial corpus. It surfaces assumptions, step-by-step rationale, and direct links to supporting UpToDate topics.
EBSCO's Dyna AI was the first major commercial AI CDSS deployment (July 2024). It uses RAG exclusively over DynaMed, DynaMedex, and Dynamic Health content, with transparent source links and an independent Generative AI Advisory Council.
ClinicalKey AI (Elsevier) expanded throughout 2025, with growing EHR integrations and the ability to earn CME/MOC credits from in-workflow clinical queries.
OpenEvidence raised $210M in Series B funding and now accounts for over a third of combined traffic between itself and UpToDate in the US, with approximately 1.5 million monthly visits. It is free for verified US healthcare professionals.
Heidi Evidence launched in February 2026 with partnerships with NICE, BMJ Group, HealthPathways, EMGuidance, and MIMS, built on Anthropic's Claude models. It is free for individual clinicians.
iatroX has continued to expand its Knowledge Centre, Brainstorm, and Quiz features, with growing coverage of US (USMLE), Canadian (MCCQE), and Australian (AMC) exam content alongside its UK core.

The common thread: every platform is moving from "search a database" to "ask a question and get a cited answer." The differentiators are now content quality, source transparency, geographic relevance, and price.

The major platforms, compared in depth

UpToDate Expert AI (Wolters Kluwer)

The incumbent. UpToDate has been the global standard for clinical reference for over two decades. Its content is authored by a network of 7,400+ physician authors and editors, covering 25+ specialties with comprehensive, narrative topic reviews.

AI layer: UpToDate Expert AI delivers conversational answers grounded exclusively in the UpToDate content library. It does not access the open internet. Key features include visible assumptions, step-by-step clinical reasoning, and single-click access to the supporting UpToDate topic.

Strengths: Unmatched content depth and editorial authority. Comprehensive narrative reviews that no AI-native tool has yet replicated. Strong institutional trust — validated in published studies linking UpToDate use to improved hospital outcomes.

Limitations: Expensive (individual US subscription ~$530/year; UK access typically institutional via NHS OpenAthens or Trust subscription). International/US-centric default perspective — UK clinicians may need to cross-reference with NICE guidelines. The Expert AI is still relatively new and evolving.

Best for: Clinicians with institutional access who need deep, comprehensive clinical reference. The gold standard for complex clinical questions.

Dyna AI / DynaMedex (EBSCO)

The first-mover. EBSCO launched Dyna AI commercially in July 2024 — over a year ahead of UpToDate's AI assistant. DynaMedex bundles DynaMed's clinical content with Micromedex drug data, creating a combined evidence + drug reference platform.

AI layer: Dyna AI uses RAG exclusively over DynaMed, DynaMedex, and Dynamic Health content. It clearly indicates the source of every claim, provides direct links, and is guided by a clinical prompt engineering team of physicians, pharmacists, and nurses. An external Generative AI Advisory Council provides independent oversight.

Strengths: Concise, "bullet-first" content style that many clinicians prefer over UpToDate's narrative approach. Explicit Levels of Evidence grading. Strong drug content via Micromedex integration. First-mover advantage means more real-world usage data and iterative improvement.

Limitations: Less brand recognition than UpToDate in many markets. The interface can feel dense for quick 30-second checks. US Dyna AI free trials available; broader access requires institutional subscription.

Best for: Clinicians who prefer concise evidence summaries with explicit grading, and those who need integrated drug reference (interactions, dosing, safety) alongside clinical content.

ClinicalKey AI (Elsevier)

The library giant. ClinicalKey sits on top of Elsevier's vast library of medical textbooks, journals, and clinical overviews. Its AI layer provides conversational access to this content.

AI layer: ClinicalKey AI offers generative answers with citations to Elsevier's proprietary content. A notable feature is the ability to earn CME/MOC credits directly from in-workflow clinical queries — the AI turns a clinical question into a learning activity.

Strengths: Deepest textbook and journal library of any clinical AI platform. Strong for clinicians who want access to full-text chapters and detailed pathophysiology alongside clinical summaries. The CME/MOC credit feature is a meaningful differentiator for US clinicians managing recertification.

Limitations: The 14-day free trial converts to a paid subscription. Less focused than UpToDate or DynaMed on synthesised clinical recommendations; more focused on providing access to source material.

Best for: Clinicians and trainees who want deep reading alongside AI-summarised answers. Particularly strong for academic settings and those who value textbook-depth content.

OpenEvidence

The disruptor. OpenEvidence is a free, AI-powered medical reference tool for verified US healthcare professionals. It searches 35M+ peer-reviewed papers and generates cited answers with a conversational interface. With $210M in Series B funding and partnerships with NEJM, JAMA, and Elsevier, it has grown explosively — from negligible traffic in 2023 to approximately 1.5 million monthly visits.

AI layer: LLM-powered search and synthesis over peer-reviewed literature. Recent feature releases include more advanced "agent-style" capabilities.

Strengths: Free for verified US HCPs. Fast. Reads the "long tail" of literature that curated databases miss. Strong for specific, niche questions.

Limitations: US-centric (often defaults to FDA approvals and US guidelines). Requires professional verification — not accessible to students or non-US clinicians without workarounds. Literature-based, not guideline-curated — it treats all published papers as "evidence" without always weighing quality appropriately. Not an MHRA-registered device.

Best for: US clinicians who want a free, fast, literature-powered alternative to UpToDate for specific clinical questions.

Heidi Evidence

The new entrant. Launched in February 2026 as part of Heidi Health's expansion from AI scribing into clinical reference. Built on Anthropic's Claude models, with content partnerships with NICE, BMJ Group, HealthPathways, EMGuidance, and MIMS.

AI layer: Conversational evidence search with selectable source sets and transparent citations. Designed to integrate seamlessly with Heidi's scribe and communications platform.

Strengths: Free for individual clinicians. Source-selectable (choose which content sets to query). Strong UK partnerships (NICE, BMJ). Natural add-on if you already use Heidi for documentation.

Limitations: Very new — launched weeks ago. Clinical validation and real-world evidence are still emerging. Tightly coupled to the Heidi ecosystem. Regulatory status in the UK to be confirmed.

Best for: Clinicians already using Heidi Scribe who want evidence lookup integrated into their documentation workflow. See our detailed comparison of Heidi Evidence vs iatroX.

iatroX

The UK-guideline-first platform. iatroX is a free, MHRA-registered (UKCA-marked Class I medical device) clinical AI platform built specifically for UK clinicians and students. It uses RAG over a curated library of UK-accepted guidelines and peer-reviewed research to deliver citation-first answers grounded in NICE, CKS, SIGN, BNF, and other trusted UK sources.

What makes it different:

Free for everyone. No subscription, no institutional login, no professional verification. Every clinician and student in the UK (and globally) can use it immediately.
UK-guideline-first. While the global platforms default to international or US guidelines, iatroX is built around the reality of NHS workflows — NICE pathways, CKS summaries, BNF prescribing, and UK-specific referral thresholds.
Multi-mode. iatroX is not just a Q&A tool. Ask iatroX provides rapid clinical answers. Brainstorm supports differential diagnosis and clinical reasoning. iatroX Quiz provides adaptive exam preparation for UKMLA, MRCGP AKT, MRCP, USMLE, MCCQE, AMC, and more. The Knowledge Centre (iKC) provides curated navigation to authoritative UK guidelines.
MHRA-registered. iatroX is a UKCA-marked Class I medical device with a DCB 0129 clinical safety case — a level of UK-specific regulatory assurance that none of the international platforms currently offer.
CPD integration. Queries can be logged as CPD reflections and exported as PDFs for appraisal portfolios — turning daily clinical use into evidenced professional development.

Limitations: Content depth is narrower than UpToDate or DynaMed for rare or highly complex conditions. Less international breadth than the global platforms. Not designed for deep literature review (use Elicit/Consensus for that).

Best for: UK clinicians (GPs, junior doctors, trainees, IMGs) who need fast, UK-guideline-grounded answers in their daily workflow. Students preparing for UK, US, Canadian, and Australian medical exams. Locum GPs who need a clinical safety net that works without institutional access.

The comparison table

Feature	UpToDate Expert AI	Dyna AI (DynaMedex)	ClinicalKey AI	OpenEvidence	Heidi Evidence	iatroX
AI architecture	RAG over UpToDate corpus	RAG over DynaMed/Micromedex	RAG over Elsevier library	LLM over 35M+ papers	RAG (Claude) over partner content	RAG over UK guidelines + research
Content source	7,400+ expert authors	Expert-curated + Micromedex	Textbooks + journals	Peer-reviewed literature	NICE, BMJ, HealthPathways, MIMS	NICE, CKS, SIGN, BNF, research
UK-guideline focus	International (US default)	International	International	US-centric	UK partnerships (NICE, BMJ)	UK-first by design
Price (individual)	~$530/year (US)	Institutional subscription	14-day trial → subscription	Free (verified US HCPs)	Free (individuals)	Free (everyone)
Professional verification	No (subscription)	No (subscription)	No (subscription)	Yes (US HCPs)	No	No
Exam preparation	No	No	CME/MOC credits	No	No	Yes (UKMLA, AKT, MRCP, USMLE, MCCQE, AMC)
Differential diagnosis	Within topic pages	Within topic pages	Within content	No	No	Yes (Brainstorm feature)
MHRA registered	N/A	N/A	N/A	No	TBC	Yes (UKCA Class I)
Mobile apps	iOS / Android	iOS / Android	iOS / Android	Web	Within Heidi app	iOS / Android / Web
Evidence grading	Graded recommendations	Explicit Levels of Evidence	Variable	Paper-level citations	Source-level citations	Confidence scores + source links
Drug reference	Limited (within topics)	Strong (Micromedex)	Within Elsevier content	Limited	Via MIMS partnership	Via BNF alignment

Which tool should you use? A decision framework

If you are a UK GP or primary care clinician:

Start with iatroX for daily guideline queries, differential diagnosis support (Brainstorm), and AKT preparation (Quiz). It is free, UK-guideline-grounded, and designed for the pace of 10-minute consultations. Add UpToDate or DynaMed (if your Trust/PCN provides access via OpenAthens) for complex cases that require deeper reference.

If you are a UK hospital doctor or specialist:

Use UpToDate or DynaMed (via institutional access) as your primary deep reference. Use iatroX for rapid NICE/CKS/BNF checks and exam preparation. Use Brainstorm for case reasoning practice and ward round preparation.

If you are a US physician:

OpenEvidence is the obvious free starting point — fast, literature-powered, and free for verified HCPs. UpToDate remains the gold standard for deep reference. Dyna AI is a strong alternative, particularly if your institution subscribes to DynaMedex. Consider iatroX for USMLE and ABIM/ABFM board preparation.

If you are a medical student or trainee:

iatroX is the best free option that combines clinical reference with exam preparation. The Quiz feature (with spaced repetition and adaptive difficulty) is purpose-built for UKMLA, MRCP, USMLE, MCCQE, and AMC. AMBOSS is the strongest paid complement for students who want an integrated library + QBank.

If you are a Canadian or Australian clinician:

UpToDate or DynaMed for primary reference. iatroX for exam preparation (MCCQE, AMC, RACGP, RACP) and for accessing UK-style guideline-grounded answers. OpenEvidence if you can access it (US verification is typically required).

The provenance test: what to ask any AI CDSS

Before trusting any AI-generated clinical answer, ask these five questions:

Where did the answer come from? Is the source a curated, expert-reviewed corpus (UpToDate, DynaMed, NICE) or the open web? Curated sources are more reliable for clinical decisions.
Can I verify the claim? Does the tool provide clickable citations that take me to the actual source document? If not, the answer is not verifiable.
Is the source current? Does the tool show when the source was last updated? A 2020 guideline may have been superseded.
Does the tool know what it doesn't know? Does the AI abstain from answering when the evidence is insufficient, or does it generate a confident-sounding answer regardless? An AI that says "I don't have enough information" is safer than one that always has an answer.
Is the tool regulated? In the UK, is it MHRA-registered? Does it have a clinical safety case (DCB 0129)? Regulation is not a guarantee of quality, but it is a signal that the vendor takes safety seriously.